Multi-target Polypharmacology of 4-aminoquinoline Compounds against Malaria, Tuberculosis and Cancer

Author:

Nandi Sisir1ORCID,Chauhan Bhumika12ORCID,Tarannum Heena13ORCID,Khede Mayank Kumar4ORCID

Affiliation:

1. Global Institute of Pharmaceutical Education and Research, Kashipur, 244713, India

2. Oxford College of Pharmacy, UPSIDC Industrial Area, Hapur, Uttar Pradesh, 201015, India

3. Pragati College of Pharmacy, Kashipur, 244713, India

4. Department of Pharmaceutics, Institute of Pharmacy and Technology, Salipur, Affiliated to Biju Patnaik University of Technology, Odisha, 754202, India

Abstract

Background: Polypharmacology means drugs having interactions with multiple targets of a unique disease or many disease pathways. This concept has been greatly appreciated against complex diseases, such as oncology, CNS disorders, and anti-infectives. Methods: The integration of diverse compounds available on public databases initiates polypharma-cological drug discovery research. Immunocompromised patients may suffer from complex diseas-es. Multiple-component drug formulations may produce side effects and resistance issues due to un-intended drug-target interactions. Results: Polypharmacology remains a novel avenue to propose a more effective and less toxic treatment. The 4-amino quinoline scaffold has become an important construction motif for the de-velopment of new drugs against lifestyle diseases like cancer and infectious diseases like tuberculo-sis and malaria. Conclusion: The present study is an attempt to explore the polypharmacological effects of 4-aminoquinoline drugs to combat malaria, cancer, and tuberculosis.

Publisher

Bentham Science Publishers Ltd.

Subject

Drug Discovery,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3